Table 2.
The summary of the clinical studies about coronavirus infectious disease-2019 infection in patients with pre-existing liver disease
| Ref. | Total number of Patients | Number of cirrhosis, n (%) | Number severe disease among cirrhosis, n (%) | Number of dismal prognosis among cirrhosis, n (%) |
| Huang et al[24] | 41 | 1 (2.4) | 0 | 0 |
| Guan et al[41] | 1099 | 23 (2.1) | 1 (4.3) | 1 (4.3) |
| Hu et al[43] | 323 | 3 (0.9) | 0 | 0 |
| Cai et al[47] | 298 | 28 (9.4) | 8 (28.6) | NS |
| Shi et al[49] | 81 | 7 (8.9) | 5 (71.4) | NS |
| Luo et al[61] | 403 | 25 (6.2) | NS | 9 (36) |
| Luo et al[62] | 298 | 16 (5.4) | NS | 5 (31.3) |
Dismal prognosis states death (n = 14) or progression of the disease (n = 1) despite suitable treatment. NS: Not specified.